Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.
The following are confirmed speakers for the 2020 Series.
Associate Director, Translational Sciences, Head, Integrated Translational Technologies Oncology Drug Development Unit
Takeda
Global Director Medical Affairs, Oncology; Thoracic Malignancies Biomarkers & Diagnostics
Merck & Co. Inc.
Scientist II, Center for Immuno-Oncology - Immune Assessment Laboratory
Dana-Farber Cancer Institute
Special Advisor and Biomarkers Consortium Cancer Steering Committee Co-Chair
National Institute of Health
Senior Director, Translational Medicine; Head of Pathology Data Science & Innovation
AstraZeneca
Director, Head of RWE & Molecular Disease Characterisation, Experimental Medicine Unit
GlaxoSmithKline
Executive Director of the Center for Microbiome Innovation, Professor of Practice, Bioengineering
UC San Diego
Professor and Deputy Chair, Chief, Section of Systems and Translational DNA Repair, Department of Systems Biology
The University of Texas MD Anderson Cancer Center